# The Use of a Mitochondrial Enhancement Treatment in Bipolar Disorder

> **NCT00719706** · PHASE2 · COMPLETED · sponsor: **Mclean Hospital** · enrollment: 40 (actual)

## Conditions studied

- Bipolar Depression

## Interventions

- **DRUG:** acetyl-l-carnitine PLUS alpha-lipoic acide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00719706
- **Lead sponsor:** Mclean Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00719706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00719706, "The Use of a Mitochondrial Enhancement Treatment in Bipolar Disorder". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00719706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*